Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgery PartnersSGRY +4.22%66 3-Year ROIIC % is 8.57 as of Dec. 2025, which is 120% above its 10-year median of 3.89. GuruFocus rates SGRY with a GF Score™ of 66/100 and a GF Value™ of $26.81 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 620 Healthcare Providers & Services companies, Surgery Partners ranks better than 59.68% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Surgery Partners's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 8.57%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Surgery Partners's 3-Year ROIIC % or its related term are showing as below:
SGRY's 3-Year ROIIC % is ranked better than 59.68% of 620
companies
in the Healthcare Providers & Services industry
Industry Median: 3.48
vs SGRY: 8.57
Surgery Partners (NAS:SGRY) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Surgery Partners 3-Year ROIIC % Related Terms
Surgery Partners 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Surgery Partners's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGRY vs AVAH, ASTH, ADUS: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Surgery Partners's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgery Partners 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Surgery Partners's 3-Year ROIIC % falls into.
Surgery Partners's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 398.2968 (Dec. 2025) - 282.31152 (Dec. 2022) )
/
( 7411 (Dec. 2025) - 6057.4 (Dec. 2022) )
=
115.98528
/
1353.6
=
8.57%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Surgery Partners (SGRY) has a 3-Year ROIIC % of 8.57 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Surgery Partners and its competitors. This is 120% above median its historical median of 3.89. According to the industry distribution chart, Surgery Partners ranks #250 out of 620 companies in the Healthcare Providers & Services industry, placing it in the top 40.3%.
Is Surgery Partners' 3-Year ROIIC % too high?
Surgery Partners' current 3-Year ROIIC % of 8.57 is 120% above median its 10-year median of 3.89. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.48. Surgery Partners' value of 8.57 is 146.3% above this industry median. Based on the distribution chart, Surgery Partners ranks #250 out of 620 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Surgery Partners has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' 3-Year ROIIC % compare to AVAH and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Surgery Partners ranks #250 out of 620 companies for 3-Year ROIIC %. This puts Surgery Partners in the upper half of its industry. The industry median 3-Year ROIIC % is 3.48. Surgery Partners' value of 8.57 is 146.3% above this benchmark. While the company's 10-year median is 3.89 vs. the industry median of 3.48, Surgery Partners has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.48, based on 620 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgery Partners's current 3-Year ROIIC % of 8.57 is 146.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Surgery Partners and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgery Partners's current 3-Year ROIIC % is 8.57, which is 120% above median its own 10-year median of 3.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (SGRY) is currently considered Possible Value Trap. The stock's GF Value™ is $26.81, compared to a current price of $15.55 — trading 42% below its estimated fair value. The current 3-Year ROIIC % is 8.57, which is 120% above median its 10-year median of 3.89 and 146.3% above the Healthcare Providers & Services industry median of 3.48. Surgery Partners' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Surgery Partners (SGRY), the current 3-Year ROIIC % is 8.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgery Partners (SGRY) Overvalued in 2026?
Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued.
The current stock price of $15.55 is trading 42% below its estimated GF Value™ of $26.81.
GuruFocus considers Surgery Partners to be Possible Value Trap.
Key valuation signals for SGRY:
3-Year ROIIC %: 8.57 (120% above median its 10-year median of 3.89)
GF Value™: $26.81 vs. price of $15.55 (42% below fair value)
Industry Position: 146.3% above the Healthcare Providers & Services median (#250 of 620)
No single metric tells the full story. See the SGRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
66GF Score
Get the complete analysis for SGRY
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGRY has been successfully added to your 
